Synthesis and Biodistribution of a New 99mTc-oxo Complex with Deoxyglucose Dithiocarbamate for Tumor Imaging

Chemical Biology and Drug Design

Volumn 79, Issue 3, 2012, Pages 239-245

  Lin, Xiao ^a   Jin, Zhonghui ^b   Ren, Jialei ^a   Pang, Yan ^a   Zhang, Weifang ^b   Huo, Jinfeng ^a   Wang, Xuebin ^a   Zhang, Junbo ^a   Zhang, Yanyan ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

99mTc oxo complex; Biodistribution; Deoxyglucose; Dithiocarbamate; Ligand exchange; Tumor

Indexed keywords

DEOXYGLUCOSE; DEOXYGLUCOSE DITHIOCARBAMATE; DITHIOCARBAMIC ACID DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GLUCEPTATE TC 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG LABELING; DRUG PURITY; DRUG RETENTION; DRUG SYNTHESIS; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE PROCEDURES; HYDROPHILICITY; IN VITRO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THIN LAYER CHROMATOGRAPHY;

ANIMALS; CARBAMATES; CELL LINE, TUMOR; COORDINATION COMPLEXES; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F18; MICE; MICE, NUDE; NEOPLASMS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

MUS;

EID: 84862827556     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01280.x     Document Type: Article

References (17)

1. 18F]-FDG in oncology: a clinical update. Nucl Med Biol;23:717-735.
2. Rigo P., Paulus P., Kaschten B.J., Hustinx R., Bury T., Jerusalem G., Benoit T., Foidart-Willems J. (1996) Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med;23:1641-1674.
3. Pauwels E.K.J., Ribeiro M.J., Stoot J.H.B.M., McCready V.R., Bourguignon M., Maziere B. (1998) FDG accumulation and tumor biology. Nucl Med Biol;25:317-322.
4. Sun Y.Y., Chen Y. (2009) Cancer drug development using glucose metabolism radiopharmaceuticals. Curr Pharm Des;15:983-987.
5. 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology;226:465-473.
6. 99mTc-ethylenedicysteine-glucosamine. Cancer Biother Radiopharm;19:443-456.
7. 186Re(I) tricarbonyl complexes of N-(2′-hydroxybenzyl)-2-amino-2-deoxy-d-glucose. Bioconjugate Chem;15:923-926.
8. Schibli R., Dumas C., Petrig J., Garcia-Garayoa E., Schubiger P.A., Spadola L., Scapozza L. (2005) Synthesis and in vitro characterization of organometallic rhenium and technetium glucose complexes against glut 1 and hexokinase. Bioconjugate Chem;16:105-112.
9. 99mTc-labeled -1-thio-β-d-glucose as a new tumor-seeking agent: synthesis and tumor cell uptake assay. Appl Radiat Isot;64:207-215.
10. Chen X.J., Li L., Liu F., Liu B.L. (2006) Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. Bioorg Med Chem Lett;16:5503-5506.
11. 99mTc]-DTPA-DG) as a potential imaging modality for tumors. Appl Radiat Isot;64:342-347.
12. 3 derivative as agent for tumor diagnosis. Bioorg Med Chem Lett;19:2497-2499.
13. 99mTc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake. Bioorg Med Chem Lett;19:2752-2754.
14. Banerjee S., Pillai M.R.A., Ramamoorthy N. (2001) Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med;31:260-277.
15. Blower P.J., Singh J., Clarke S.E.M. (1991) The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med;32:845-849.
16. 99mTc complexes of L, L-EC and L, L-ECD. Nucl Med Biol;23:987-993.
17. Yaoita H., Fischman A.J., Wilkinson R., Khaw B.A., Juweid M., Strauss H.W. (1993) Distribution of deoxyglucose and technetium-99m glucarate in the acutely ischemic myocardium. J Nucl Med;34:1303-1308.